128 related articles for article (PubMed ID: 37978484)
1. Association of known SARS-CoV-2 serostatus and adherence to personal protection measures and the impact of personal protective measures on seropositivity in a population-based cross-sectional study (MuSPAD) in Germany.
Kettlitz R; Harries M; Ortmann J; Krause G; ; Aigner A; Lange B
BMC Public Health; 2023 Nov; 23(1):2281. PubMed ID: 37978484
[TBL] [Abstract][Full Text] [Related]
2. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
[TBL] [Abstract][Full Text] [Related]
3. Physical interventions to interrupt or reduce the spread of respiratory viruses.
Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
[TBL] [Abstract][Full Text] [Related]
4. Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study.
Rader B; White LF; Burns MR; Chen J; Brilliant J; Cohen J; Shaman J; Brilliant L; Kraemer MUG; Hawkins JB; Scarpino SV; Astley CM; Brownstein JS
Lancet Digit Health; 2021 Mar; 3(3):e148-e157. PubMed ID: 33483277
[TBL] [Abstract][Full Text] [Related]
5. Protective behavior and SARS-CoV-2 infection risk in the population - Results from the Gutenberg COVID-19 study.
Baumkötter R; Yilmaz S; Zahn D; Fenzl K; Prochaska JH; Rossmann H; Schmidtmann I; Schuster AK; Beutel ME; Lackner KJ; Münzel T; Wild PS
BMC Public Health; 2022 Oct; 22(1):1993. PubMed ID: 36316662
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.
Lone KS; Khan SMS; Qurieshi MA; Majid S; Pandit MI; Haq I; Ahmad J; Bhat AA; Bashir K; Bilquees S; Fazili AB; Hassan M; Jan Y; Kaul RR; Khan ZA; Mushtaq B; Nazir F; Qureshi UA; Raja MW; Rasool M; Asma A; Bhat AA; Chowdri IN; Ismail S; Jeelani A; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Qazi TB; Rather RH; Sabah I; Sumji IA
Front Public Health; 2022; 10():967447. PubMed ID: 36276377
[TBL] [Abstract][Full Text] [Related]
7. Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and vaccine antibody prevalence in a multi-ethnic inner-city antenatal population: A cross-sectional surveillance study.
Andreeva D; Gill C; Brockbank A; Hejmej J; Conti-Ramsden F; Doores KJ; Seed PT; Poston L;
BJOG; 2023 Aug; 130(9):1135-1144. PubMed ID: 37113111
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies among unvaccinated children of Chandigarh, Northwest India, in a household-based paediatric serosurvey post-second wave of pandemic (June to July 2021).
Ghosh A; Goyal K; Singh R; Lakshmi PVM; Kaur R; Kumar V; Muralidharan J; Puri GD; Ram J; Singh MP
Public Health; 2023 Dec; 225():160-167. PubMed ID: 37931485
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Infection-and mRNA Vaccine-induced Humoral Immunity among Schoolchildren in Hawassa, Ethiopia.
Merid Y; Tekleselasie W; Tesfaye E; Gadisa A; Fentahun D; Abate A; Alemu A; Mihret A; Mulu A; Gelanew T
Front Immunol; 2023; 14():1163688. PubMed ID: 37398668
[TBL] [Abstract][Full Text] [Related]
12. Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany.
Dulovic A; Kessel B; Harries M; Becker M; Ortmann J; Griesbaum J; Jüngling J; Junker D; Hernandez P; Gornyk D; Glöckner S; Melhorn V; Castell S; Heise JK; Kemmling Y; Tonn T; Frank K; Illig T; Klopp N; Warikoo N; Rath A; Suckel C; Marzian AU; Grupe N; Kaiser PD; Traenkle B; Rothbauer U; Kerrinnes T; Krause G; Lange B; Schneiderhan-Marra N; Strengert M
Front Immunol; 2022; 13():828053. PubMed ID: 35251012
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany.
Tönshoff B; Müller B; Elling R; Renk H; Meissner P; Hengel H; Garbade SF; Kieser M; Jeltsch K; Grulich-Henn J; Euler J; Stich M; Chobanyan-Jürgens K; Zernickel M; Janda A; Wölfle L; Stamminger T; Iftner T; Ganzenmueller T; Schmitt C; Görne T; Laketa V; Olberg S; Plaszczyca A; Cortese M; Bartenschlager R; Pape C; Remme R; Huzly D; Panning M; Weigang S; Giese S; Ciminski K; Ankerhold J; Kochs G; Schwemmle M; Handgretinger R; Niemeyer CM; Engel C; Kern WV; Hoffmann GF; Franz AR; Henneke P; Debatin KM; Kräusslich HG
JAMA Pediatr; 2021 Jun; 175(6):586-593. PubMed ID: 33480966
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 infection and associated factors among Bangladeshi slum and non-slum dwellers in pre-COVID-19 vaccination era: October 2020 to February 2021.
Raqib R; Sarker P; Akhtar E; Nurul Huda TM; Haq MA; Roy AK; Hosen MB; Haque F; Chowdhury MR; Reidpath DD; Emdadul Hoque DM; Islam Z; Ahmed S; Ahmed T; Tofail F; Razzaque A
PLoS One; 2022; 17(5):e0268093. PubMed ID: 35604947
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study.
Doucette EJ; Gray J; Fonseca K; Charlton C; Kanji JN; Tipples G; Kuhn S; Dunn J; Sayers P; Symonds N; Wu G; Freedman SB; Kellner JD
PLoS One; 2023; 18(4):e0284046. PubMed ID: 37023007
[TBL] [Abstract][Full Text] [Related]
16. Publisher Correction to: Association of known SARS-CoV-2 serostatus and adherence to personal protection measures and the impact of personal protective measures on seropositivity in a population-based cross-sectional study (MuSPAD) in Germany.
Kettlitz R; Harries M; Ortmann J; Krause G; ; Aigner A; Lange B
BMC Public Health; 2024 Feb; 24(1):593. PubMed ID: 38395912
[No Abstract] [Full Text] [Related]
17. The Effect of Preventive Measures and Vaccination against SARS-CoV-2 on the Infection Risk, Treatment, and Hospitalization: A Cross-Sectional Study of Algeria.
Hamimes A; Aouissi HA; Ababsa M; Lounis M; Jayarajah U; Napoli C; Kasemy ZA
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560775
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.
Bundgaard H; Bundgaard JS; Raaschou-Pedersen DET; von Buchwald C; Todsen T; Norsk JB; Pries-Heje MM; Vissing CR; Nielsen PB; Winsløw UC; Fogh K; Hasselbalch R; Kristensen JH; Ringgaard A; Porsborg Andersen M; Goecke NB; Trebbien R; Skovgaard K; Benfield T; Ullum H; Torp-Pedersen C; Iversen K
Ann Intern Med; 2021 Mar; 174(3):335-343. PubMed ID: 33205991
[TBL] [Abstract][Full Text] [Related]
19. [SARS-CoV-2 Exposure and Seroprevalence of SARS-CoV-2 Antibodies among Medical Students in the First Phase of the Pandemic 2020-2021].
Landmesser P; Weissbrich B; Peter-Kern M; Krone M; Liese JG; Streng A
Gesundheitswesen; 2024 Apr; 86(4):311-314. PubMed ID: 38181814
[TBL] [Abstract][Full Text] [Related]
20. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM
Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
